|
| U.S. Brand Names |
| Polycitra® |
 |
| Generic Available |
|
Yes |
|
| Pharmacological Index |
|
Alkalinizing Agent |
|
| Use |
|
Conditions where long-term maintenance of an alkaline urine is desirable as in control and dissolution of uric acid and cystine calculi of the urinary tract |
|
| Pregnancy Risk Factor |
|
Not established |
|
| Usual Dosage |
|
Oral: Adults: 15-30 mL diluted in water after meals and at bedtime |
|
| Dietary Considerations |
|
Should be administered after meals |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
Palatability is improved by chilling solution, dilute each dose with 1-3 oz of water and follow with additional water; take after meals to prevent saline laxative effect |
|
| Nursing Implications |
|
Dilute each dose in 30-90 mL of water prior to administration |
|
| Dosage Forms |
|
Syrup: Sodium citrate 500 mg, potassium citrate 550 mg, with citric acid 334 mg per 5 mL [sodium 1 mEq, potassium 1 mEq, bicarbonate 2 mEq] |
|
|
Copyright © 2007 Drugs Area |
